Targeting NO Signaling for the Treatment of Osteoporosis

E-ISSN： 1875-533x|23|24|2746-2753

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.24, 2016-08, pp. : 2746-2753

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis

By Jules Joel Ashley Jason W Feng Xu

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 9, 2010-09 ,pp. : 923-934

Informa Healthcare

Access to resources Recommend Favorite

Targeting Insulin Signaling for the Treatment of Alzheimer's Disease

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 5, 2016-02 ,pp. : 485-492

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Adenosine Signaling to Treatment of Diabetic Nephropathy

Current Drug Targets, Vol. 14, Iss. 4, 2013-04 ,pp. : 490-496

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2899-2911

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the PDGF Signaling Pathway in the Treatment of Non-Malignant Diseases

By Heldin Carl-Henrik

Journal of Neuroimmune Pharmacology, Vol. 9, Iss. 2, 2014-03 ,pp. : 69-79

Springer Publishing Company

Access to resources Recommend Favorite